These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 10468889)

  • 1. Differential expression of and responsiveness to transforming growth factor-beta (TGF-beta) isoforms in hormone-dependent and independent lines of mouse mammary tumors.
    Viegas MH; Salatino M; Goin M; Peters G; Labriola L; Costa da cunha J; Lanari C; Charreau EH; Elizalde PV
    Cancer Detect Prev; 1999; 23(5):375-86. PubMed ID: 10468889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor-beta activities in 'in vivo' lines of hormone-dependent and independent mammary adenocarcinomas induced by medroxyprogesterone acetate in BALB/c mice.
    Elizalde PV; Lanari C; Kordon E; Tezón J; Charreau EH
    Breast Cancer Res Treat; 1990 Jul; 16(1):29-39. PubMed ID: 2145045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of TGF-beta 1 expression with medroxyprogesterone acetate responsiveness in mouse mammary adenocarcinomas.
    Elizalde PV; Guerra FK; Gravano M; Lanari C; Lippman ME; Charreau EH; Lupu R
    Cancer Invest; 1995; 13(2):173-80. PubMed ID: 7874571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of cell cycle arrest in response to TGF-beta in progestin-dependent and -independent growth of mammary tumors.
    Salatino M; Labriola L; Schillaci R; Charreau EH; Elizalde PV
    Exp Cell Res; 2001 Apr; 265(1):152-66. PubMed ID: 11281653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of insulin-like growth factors-I and -II and their receptors in medroxyprogesterone acetate-induced growth of mouse mammary adenocarcinomas.
    Elizalde PV; Lanari C; Molinolo AA; Guerra FK; Balañá ME; Simian M; Iribarren AM; Charreau EH
    J Steroid Biochem Mol Biol; 1998 Nov; 67(4):305-17. PubMed ID: 9883987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Desensitization of melanoma cells to autocrine TGF-beta isoforms.
    Krasagakis K; Krüger-Krasagakes S; Fimmel S; Eberle J; Thölke D; von der Ohe M; Mansmann U; Orfanos CE
    J Cell Physiol; 1999 Feb; 178(2):179-87. PubMed ID: 10048582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factors beta1, beta2 and beta3 and their receptors are differentially expressed in human peritoneal fibroblasts in response to hypoxia.
    Saed GM; Collins KL; Diamond MP
    Am J Reprod Immunol; 2002 Dec; 48(6):387-93. PubMed ID: 12607775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Growth hormones and oncogenes in mammary adenocarcinomas induced by medroxyprogesterone acetate in BALB/c mice].
    Elizalde PV; Balaña ME; Charreau EH
    Medicina (B Aires); 1997; 57 Suppl 2():70-4. PubMed ID: 9580484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five novel hormone-responsive cell lines derived from murine mammary ductal carcinomas: in vivo and in vitro effects of estrogens and progestins.
    Lanari C; Lüthy I; Lamb CA; Fabris V; Pagano E; Helguero LA; Sanjuan N; Merani S; Molinolo AA
    Cancer Res; 2001 Jan; 61(1):293-302. PubMed ID: 11196177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of transforming growth factor alpha (TGF alpha) in differentiated rat mammary tumors: estrogen induction of TGF alpha production.
    Liu SC; Sanfilippo B; Perroteau I; Derynck R; Salomon DS; Kidwell WR
    Mol Endocrinol; 1987 Oct; 1(10):683-92. PubMed ID: 2484711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in levels of mRNAs of transforming growth factor (TGF)-beta1, -beta2, -beta3, TGF-beta type II receptor and sulfated glycoprotein-2 during apoptosis of mouse uterine epithelium.
    Wada K; Nomura S; Morii E; Kitamura Y; Nishizawa Y; Miyake A; Terada N
    J Steroid Biochem Mol Biol; 1996 Dec; 59(5-6):367-75. PubMed ID: 9010342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitation of TGF-β proteins in mouse tissues shows reciprocal changes in TGF-β1 and TGF-β3 in normal vs neoplastic mammary epithelium.
    Flanders KC; Yang YA; Herrmann M; Chen J; Mendoza N; Mirza AM; Wakefield LM
    Oncotarget; 2016 Jun; 7(25):38164-38179. PubMed ID: 27203217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucocorticoids modulate TGF-beta production by human fetal lung fibroblasts.
    Wen FQ; Kohyama T; Sköld CM; Zhu YK; Liu X; Romberger DJ; Stoner J; Rennard SI
    Inflammation; 2003 Feb; 27(1):9-19. PubMed ID: 12772773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of proliferation and migration in retinoic acid treated C3H10T1/2 cells by TGF-beta isoforms.
    Makhijani NS; Bischoff DS; Yamaguchi DT
    J Cell Physiol; 2005 Jan; 202(1):304-13. PubMed ID: 15389595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinoma-associated fibroblasts activate progesterone receptors and induce hormone independent mammary tumor growth: A role for the FGF-2/FGFR-2 axis.
    Giulianelli S; Cerliani JP; Lamb CA; Fabris VT; Bottino MC; Gorostiaga MA; Novaro V; Góngora A; Baldi A; Molinolo A; Lanari C
    Int J Cancer; 2008 Dec; 123(11):2518-31. PubMed ID: 18767044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions between progestins and heregulin (HRG) signaling pathways: HRG acts as mediator of progestins proliferative effects in mouse mammary adenocarcinomas.
    Balañá ME; Lupu R; Labriola L; Charreau EH; Elizalde PV
    Oncogene; 1999 Nov; 18(46):6370-9. PubMed ID: 10597237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction in transforming growth factor-beta type II receptor in mouse lung carcinogenesis.
    Jakowlew SB; Moody TW; You L; Mariano JM
    Mol Carcinog; 1998 May; 22(1):46-56. PubMed ID: 9609100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inoculated mammary carcinoma-associated fibroblasts: contribution to hormone independent tumor growth.
    Fabris VT; Sahores A; Vanzulli SI; Colombo L; Molinolo AA; Lanari C; Lamb CA
    BMC Cancer; 2010 Jun; 10():293. PubMed ID: 20553594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and secretion of TGF-beta isoforms and expression of TGF-beta-receptors I, II and III in normal and neoplastic human breast.
    Chakravarthy D; Green AR; Green VL; Kerin MJ; Speirs V
    Int J Oncol; 1999 Jul; 15(1):187-94. PubMed ID: 10375614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to growth inhibition by transforming growth factor-beta in malignant glioma cells with functional receptors.
    Isoe S; Naganuma H; Nakano S; Sasaki A; Satoh E; Nagasaka M; Maeda S; Nukui H
    J Neurosurg; 1998 Mar; 88(3):529-34. PubMed ID: 9488308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.